MedPath

Investigating effects of CO-OP approach in Individuals with Parkinson’s Disease

Not Applicable
Recruiting
Conditions
Parkinson's disease.
Parkinson's disease
Registration Number
IRCT20210901052356N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Diagnosis of Parkinson’s Disease by a neurologist
Hoehn and Yahr scale score between stages 1-3
A minimum score of 16 out of 30 on the Montreal Test
No other neurological or psychological problems
Not having a verbal problem
And the ability to understand the global strategy of the CO-OP approach

Exclusion Criteria

Comorbidity with cognitive impairments such as: Alzheimer, stroke, brain injury, multiple sclerosis, etc.
Lack of cooperation and willingness to continue cooperation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Performance and satisfaction scores of client-chosen goal. Timepoint: pretest , post test and follow-up (one months after last session). Method of measurement: Canadian Occupational Performance Measurement (COPM).
Secondary Outcome Measures
NameTimeMethod
Goal Attainment. Timepoint: Pretest, post test and follow-up. Method of measurement: Goal Attainment Scale (GAS).;Activities of Daily Living. Timepoint: Pretest, post test and follow-up. Method of measurement: Functional Independence Measure (FIM).;Fatigue. Timepoint: Pretest, post test and follow-up. Method of measurement: Parkinson Fatigue Scale (PFS).
© Copyright 2025. All Rights Reserved by MedPath